Issued Patents All Time
Showing 25 most recent of 218 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12428420 | Tricyclic heterocycles as FGFR inhibitors | Robert Swyka, Evan Styduhar, Xin Li, Oleg Vechorkin | 2025-09-30 |
| 12384778 | Pyrazolopyridine compounds and uses thereof | Oleg Vechorkin, Jun Pan, Kai Liu, Alexander Sokolsky, Anlai Wang +2 more | 2025-08-12 |
| 12378243 | Quinoline compounds as inhibitors of KRAS | Qinda Ye, Matthew S. McCammant, Rocco Policarpo, Artem Shvartsbart, Wenyu Zhu +13 more | 2025-08-05 |
| 12331063 | Hetero-bicyclic inhibitors of KRAS | Alexander Sokolsky, Chang Min, Xiaozhao Wang | 2025-06-17 |
| 12312331 | Imidazolyl pyrimidinylamine compounds as CDK2 inhibitors | Qinda Ye, Jingwei Li, Ken Mukai, Brandon Smith, Liangxing Wu +4 more | 2025-05-27 |
| 12247038 | Pyrido[3,2-d]pyrimidine compounds as immunomodulators | Jingwei Li, Liangxing Wu | 2025-03-11 |
| 12247026 | Heterocyclic compounds as immunomodulators | Liangxing Wu, Jingwei Li | 2025-03-11 |
| 12201636 | Heterocyclylamines as PI3K inhibitors | Yun-Long Li, Andrew P. Combs, Eddy W. Yue, Song Mei, Joseph Glenn +2 more | 2025-01-21 |
| 12187743 | Heterocyclic compounds as immunomodulators | Liangxing Wu, Kaijiong Xiao | 2025-01-07 |
| 12187725 | Tricyclic urea compounds as JAK2 V617F inhibitors | Yanran Ai, Yu Sheng Bai, Joseph Barbosa, Hao Feng, Leah C. Konkol +5 more | 2025-01-07 |
| 12129267 | Heteroaryl amide compounds as sting activators | Liangxing Wu, Neil Lajkiewicz | 2024-10-29 |
| 12122767 | Bicyclic heterocycles as FGFR inhibitors | Oleg Vechorkin, Hai Fen Ye | 2024-10-22 |
| 12083124 | Bicyclic heterocycles as FGFR inhibitors | Oleg Vechorkin, Minh Ngoc Nguyen, Chao Qi, Anlai Wang, Michael Witten +4 more | 2024-09-10 |
| 12084449 | Imidazotriazines and imidazopyrimidines as kinase inhibitors | Jincong Zhuo, Meizhong Xu, Chunhong He, Colin Zhang, Ding-Quan Qian +3 more | 2024-09-10 |
| 12077539 | Imidazole and triazole KRAS inhibitors | Chao Qi, Xiaozhao Wang | 2024-09-03 |
| 12060433 | CD73 inhibitor and A2A/A2B adenosine receptor inhibitor combination therapy | Horacio G. Nastri, Shaun M. Stewart, Juan Carlos Almagro, Jing Zhou, Rebecca A. Buonpane +9 more | 2024-08-13 |
| 12030889 | Imidazopyridazine and imidazopyridine compounds and uses thereof | Jun Pan, Jeremy Roach, Song Mei, Chunhong He, Liangxing Wu | 2024-07-09 |
| 12030883 | Hetero-tricyclic compounds as inhibitors of KRAS | Peter Carlsen, Ken Mukai, Haolin Yin, Xiaozhao Wang, Wenyu Zhu | 2024-07-09 |
| 12030884 | Pyrazoloquinoline KRAS inhibitors | Wenyu Zhu, Xiaozhao Wang | 2024-07-09 |
| 12012409 | Bicyclic heterocycles as FGFR inhibitors | Jeremy Roach, Artem Shvartsbart, Michael Witten | 2024-06-18 |
| 11999752 | Vinyl imidazole compounds as inhibitors of KRAS | Peter Carlsen, Xiaozhao Wang, Alexander Sokolsky, Pei Gan, Rocco Policarpo | 2024-06-04 |
| 11999740 | Fused pyrazine derivatives as A2A / A2B inhibitors | Xiaozhao Wang, Peter Carlsen, Pei Gan, Gia Hoang, Yong Li +3 more | 2024-06-04 |
| 11958861 | Spirocyclic lactams as JAK2 V617F inhibitors | Stacey Shepard, Charles Cole, Nikoo Falahatpisheh, Kai Liu, Lixin Shao +3 more | 2024-04-16 |
| 11939331 | Tricyclic heterocycles as FGFR inhibitors | Xin Li, Evan Styduhar, Robert Swyka, Oleg Vechorkin | 2024-03-26 |
| 11939328 | Quinoline compounds as inhibitors of KRAS | Qinda Ye, Matthew S. McCammant, Artem Shvartsbart, Wenyu Zhu, Bin Hu +3 more | 2024-03-26 |